James Healy Cin Cor Pharma, Inc. (CINC) insider trading activity

CINC Quotes by TradingView

JAMES HEALY Transaction History

Date Transaction Value Shares Traded Form
Feb 24 2023
SELL
Disposition due to a tender of shares in a change of control transaction
-
6,073,949
Nov 28 2022
SELL
Open market or private sale
$85,920 $14.32 p/Share
6,000
Aug 11 2022
BUY
Open market or private purchase
$15,180,000 $30.0 p/Share
506,000
Jan 11 2022
BUY
Conversion of derivative security
-
5,248,949
Jan 11 2022
BUY
Open market or private purchase
$5,200,000 $16.0 p/Share
325,000

Also insider at

HGEN
HUMANIGEN, INC Healthcare
Director
CHRS
Coherus BioSciences, Inc. Healthcare
Director
BOLT
Bolt Biotherapeutics, Inc. Healthcare
NTRA
Natera, Inc. Healthcare
YMAB
Y-mAbs Therapeutics, Inc. Healthcare
Director
KRTX
Karuna Therapeutics, Inc. Healthcare
AVBP
ArriVent Biopharma, Inc.
Director
RAPP
Rapport Therapeutics, Inc.
Director
JH

James Healy

Director
Menlo Park, CA

Track Institutional and Insider Activities on CINC

Follow CinCor Pharma, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CINC shares.

Notify only if

Insider Trading

Get notified when an Cin Cor Pharma, Inc. insider buys or sells CINC shares.

Notify only if

News

Receive news related to CinCor Pharma, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CINC